Silencing TNFRSF13B increased the expression of p53 and suppressed p53-expressing 22Rv1 cell growth, whereas cell proliferation was not affected in p53-null PC-3 cells, suggesting that p53 status might be associated with TNFRSF13B-driven prostate cancer cell proliferation [55]. The gene discussed is TP53; the disease is prostate carcinoma.